Hopewell Therapeutics
Biotechnology, 216 W Cummings Park, Woburn, , 1801, Massachusetts, United States, 11-50 Employees
Phone Number: 78********
Who is HOPEWELL THERAPEUTICS
Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. We are pursui...
Read More
-
Headquarters: 216 W Cummings Park, Woburn, Massachusetts, 1801, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 325414 |
Show More
Does something look wrong? Fix it. | View contact records from HOPEWELL THERAPEUTICS
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Hopewell Therapeutics
Answer: Hopewell Therapeutics's headquarters are located at 216 W Cummings Park, Woburn, , 1801, Massachusetts, United States
Answer: Hopewell Therapeutics's phone number is 78********
Answer: Hopewell Therapeutics's official website is https://hopewell-tx.com
Answer: Hopewell Therapeutics's revenue is $1 Million to $5 Million
Answer: Hopewell Therapeutics's SIC: 2836
Answer: Hopewell Therapeutics's NAICS: 325414
Answer: Hopewell Therapeutics has 11-50 employees
Answer: Hopewell Therapeutics is in Biotechnology
Answer: Hopewell Therapeutics contact info: Phone number: 78******** Website: https://hopewell-tx.com
Answer: Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. We are pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry leading companies. We are developing our own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of our ttLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases and neurological disorders.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month